Health Lynked Corp HLYK
We take great care to ensure that the data presented and summarized in this overview for HealthLynked Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in HLYK
Top Purchases
Top Sells
About HLYK
HealthLynked Corp. operates a cloud-based patient information network and record archiving system in the United States. It operates through four divisions: Health Services, Digital HealthCare, Accountable Care Organization/Managed Service Organization (ACO/MSO), and Medical Distribution. The Health Services division provides obstetrical and gynecological medical services to patients; functional medicine focusing on neurodegenerative diseases, such as Alzheimer's, Parkinson's, and multiple sclerosis; and Bridging the Gap Physical Therapy, a physical therapy practice to speed patients' recovery and manage pain without pain medication or surgery. The Digital HealthCare division operates HealthLynked Network, which enables patients and doctors to keep track of medical information via internet in a cloud-based system; and enables patients to enter a detailed online personal medical history, including past surgical history, medications, allergies, and family medical history. This segment also offers online scheduling function for patients to book appointments with providers. The ACO/MSO division operates an ACO and MSO that assists physician practices in providing care to patients via the Medicare Shared Savings Program; and offers contracted consulting services to healthcare providers and other ACOs. The Medical Distribution Division operates as a virtual distributor of discounted medical supplies selling to consumers and medical practice. The company was incorporated in 2014 and is headquartered in Naples, Florida.
Insider Transactions at HLYK
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 24
2024
|
David Rosal Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
28,333
+31.37%
|
$0
$0.08 P/Share
|
Jun 20
2024
|
David Rosal Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
33,667
+50.0%
|
$0
$0.08 P/Share
|
Sep 27
2023
|
Heather Monahan Director |
BUY
Grant, award, or other acquisition
|
Direct |
408,163
+25.67%
|
-
|
Sep 27
2023
|
Robert P Gasparini Director |
BUY
Grant, award, or other acquisition
|
Direct |
408,163
+12.41%
|
-
|
Sep 27
2023
|
Paul Hobaica Director |
BUY
Grant, award, or other acquisition
|
Direct |
408,163
+41.77%
|
-
|
Sep 27
2023
|
Daniel L. Hall Director |
BUY
Grant, award, or other acquisition
|
Direct |
408,163
+25.67%
|
-
|
Jan 27
2023
|
George O'Leary Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+5.11%
|
-
|
Jan 27
2023
|
Michael T Dent Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+1.63%
|
-
|
Dec 08
2022
|
Heather Monahan Director |
BUY
Grant, award, or other acquisition
|
Direct |
536,193
+40.94%
|
-
|
Dec 08
2022
|
Daniel L. Hall Director |
BUY
Grant, award, or other acquisition
|
Direct |
536,193
+40.94%
|
-
|
Dec 08
2022
|
Robert P Gasparini Director |
BUY
Grant, award, or other acquisition
|
Direct |
536,193
+17.82%
|
-
|
Oct 20
2022
|
George O'Leary Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+31.27%
|
-
|
Dec 21
2021
|
George O'Leary Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+0.42%
|
-
|
Dec 21
2021
|
Michael T Dent Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+0.07%
|
-
|
Nov 12
2021
|
Daniel L. Hall Director |
BUY
Grant, award, or other acquisition
|
Direct |
68,942
+22.95%
|
-
|
Nov 12
2021
|
Robert P. Mino Director |
BUY
Grant, award, or other acquisition
|
Direct |
68,942
+9.82%
|
-
|
Nov 12
2021
|
Heather Monahan Director |
BUY
Grant, award, or other acquisition
|
Direct |
68,942
+22.95%
|
-
|
Nov 12
2021
|
Robert P Gasparini Director |
BUY
Grant, award, or other acquisition
|
Direct |
68,942
+3.45%
|
-
|
Jul 21
2021
|
Robert P Gasparini Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
312,250
+14.93%
|
$0
$0.1 P/Share
|
Apr 30
2021
|
Robert P Gasparini Director |
BUY
Grant, award, or other acquisition
|
Direct |
354,234
+19.45%
|
-
|
Last 12 Months Summary
Open market or private purchase | 62K shares |
---|